Congenital hypothyroidism

Area of Science:

• Pediatric Endocrinology
• Neonatal Screening
• Thyroid Disorders

Background:

• Congenital hypothyroidism (CH) is a leading preventable cause of mental retardation.
• Most CH cases stem from thyroid dysgenesis (85%) or dyshormonogenesis (15%).
• Subtle clinical signs necessitate universal newborn screening to avoid severe outcomes like intellectual disability.

Purpose of the Study:

• To highlight the critical importance of neonatal screening for congenital hypothyroidism.
• To outline diagnostic and confirmatory testing protocols for CH.
• To emphasize timely treatment with levothyroxine for optimal neurodevelopmental outcomes.

Main Methods:

• Neonatal screening using dried capillary blood spots (TSH or T4) between 2-5 days of age.
• Immediate recall and confirmatory serum testing (TSH, free or total T4) for abnormal screening results.
• Comparison of serum hormone levels with age-specific reference ranges.

Main Results:

• Early diagnosis and treatment are inversely related to intelligence quotient (IQ).
• Prompt initiation of levothyroxine therapy is essential.
• Therapeutic goals include normalizing T4 within 2 weeks and TSH within 1 month.

Conclusions:

• Neonatal screening for CH is vital for preventing intellectual disability.
• Prompt and appropriate levothyroxine treatment is key to ensuring normal growth and neurodevelopment.
• Adherence to established treatment protocols maximizes the potential for positive long-term outcomes.